Almekinders, Mathilde M. http://orcid.org/0000-0002-1554-2887
Bismeijer, Tycho http://orcid.org/0000-0001-6514-4767
Kumar, Tapsi http://orcid.org/0000-0003-2825-3387
Yang, Fei
Thijssen, Bram http://orcid.org/0000-0003-1562-2649
van der Linden, Rianne
van Rooijen, Charlotte
Vonk, Shiva
Sun, Baohua
Parra Cuentas, Edwin R. http://orcid.org/0000-0001-9068-1636
Wistuba, Ignacio I.
Krishnamurthy, Savitri
Visser, Lindy L. http://orcid.org/0000-0001-7856-1981
Seignette, Iris M.
Hofland, Ingrid
Sanders, Joyce http://orcid.org/0000-0002-0551-7813
Broeks, Annegien
Love, Jason K.
Menegaz, Brian http://orcid.org/0000-0002-3020-5790
Wessels, Lodewyk
Thompson, Alastair M.
de Visser, Karin E.
Hooijberg, Erik
Lips, Esther http://orcid.org/0000-0003-3488-4935
Futreal, Andrew http://orcid.org/0000-0001-8663-2671
Wesseling, Jelle http://orcid.org/0000-0002-8940-2676
Lips, Esther
Wesseling, Jelle
Wessels, Lodewyk
Futreal, Andrew
Thompson, Alastair M.
,
Article History
Received: 23 November 2021
Revised: 17 May 2022
Accepted: 7 June 2022
First Online: 29 June 2022
Competing interests
: The authors declare no competing interests.
: The study was approved by the review boards of the Netherlands Cancer Registry (NKR request K12.281; January 3, 2013) the Dutch National Pathology Automated Archive (PALGA, LZV990; April 16, 2013) and the locoregional institutional review board within the Netherlands Cancer Institute. The secondary use of tissue and data in this study are covered by an opt-out regimen conform Dutch regulations, the Codes of Conduct of Federa-COREON [CitationRef removed] and the international Guideline on Good Clinical Practice. The study also meets the General Data Protection Regulation (GDPR) criteria that came into effect on 25 May 2018.